Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:LX News 24 November 2025 - 9 January 2026

Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

Qfin Holdings shares dropped 4.5% to $17.32 in Friday afternoon trading, hitting a session low of $17.21. FinVolution and LexinFintech also declined, as investors weighed U.S. tariff uncertainty and concerns over rising Chinese consumer loan defaults. China’s regulator recently extended a program for banks to offload bad loans. The broader U.S. market traded higher.
9 January 2026
·····
LX Stock Today (November 24, 2025): LexinFintech Jumps on Strong Q3 Earnings and Steady 2025 Guidance

LX Stock Today (November 24, 2025): LexinFintech Jumps on Strong Q3 Earnings and Steady 2025 Guidance

LexinFintech Holdings Ltd. (NASDAQ: LX) shares pushed sharply higher on Monday after the Chinese fintech group reported robust third‑quarter 2025 earnings and reaffirmed its full‑year profit outlook despite tightening regulation in its home market. At the close of U.S. trading on November 24, LX finished around $3.78, up roughly 8% on the day. The stock traded between about $3.60 and $4.08, with turnover of just over 4 million ADSs, above its recent average volume of roughly 3.5 million shares.Finviz The move comes as investors digest a mixed but generally resilient Q3 report: profits are surging, revenue is slightly down, and
24 November 2025
···

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop